Advanced search

Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 multicenter phase III trial.

(2002) JOURNAL OF CLINICAL ONCOLOGY. 20(14). p.3114-3121
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
BIGANZOLI, L, T CUFER, P BRUNING, R COLEMAN, Luc Duchateau, AH CALVERT, T GAMUCCI, et al. 2002. “Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial.” Journal of Clinical Oncology 20 (14): 3114–3121.
APA
BIGANZOLI, L., CUFER, T., BRUNING, P., COLEMAN, R., Duchateau, L., CALVERT, A., GAMUCCI, T., et al. (2002). Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 multicenter phase III trial. JOURNAL OF CLINICAL ONCOLOGY, 20(14), 3114–3121.
Vancouver
1.
BIGANZOLI L, CUFER T, BRUNING P, COLEMAN R, Duchateau L, CALVERT A, et al. Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 multicenter phase III trial. JOURNAL OF CLINICAL ONCOLOGY. 2002;20(14):3114–21.
MLA
BIGANZOLI, L, T CUFER, P BRUNING, et al. “Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial.” JOURNAL OF CLINICAL ONCOLOGY 20.14 (2002): 3114–3121. Print.
@article{149290,
  author       = {BIGANZOLI, L and CUFER, T and BRUNING, P and COLEMAN, R and Duchateau, Luc and CALVERT, AH and GAMUCCI, T and TWELVES, C and FARGEOT, P and EPELBAUM, R and LOHRISCH, C and PICCART, MJ},
  issn         = {0732-183X},
  journal      = {JOURNAL OF CLINICAL ONCOLOGY},
  language     = {eng},
  number       = {14},
  pages        = {3114--3121},
  title        = {Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 multicenter phase III trial.},
  volume       = {20},
  year         = {2002},
}

Web of Science
Times cited: